1
Registered trials
0
Recruiting
1
Unique sponsors
1
Unique IMPs
1
Commercial trials
Drug classes (ATC)
—
ATC code not specified
1
Mechanism of action (INN-stem analysis)
Monoclonal antibody (unknown source)
1 substance
Phase III:
1
Phase III
1 trial-
PendingRegeneron Pharmaceuticals Inc. CommercialMIBAVADEMAB
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | Commercial | 1 | Phase III | 0 |